Amedisys Analyst Ratings
Amedisys Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
07/31/2023 | 11.24% | TD Cowen | $84 → $101 | Maintains | Market Perform |
07/27/2023 | 11.24% | Credit Suisse | → $101 | Reiterates | Neutral → Neutral |
07/06/2023 | 11.24% | Jefferies | $98 → $101 | Downgrades | Buy → Hold |
06/28/2023 | — | Benchmark | Downgrades | Buy → Hold | |
06/27/2023 | — | Benchmark | Downgrades | Buy → Hold | |
06/27/2023 | 11.24% | Truist Securities | $97 → $101 | Maintains | Hold |
06/07/2023 | 6.84% | Truist Securities | → $97 | Downgrades | Buy → Hold |
06/06/2023 | 10.14% | Cantor Fitzgerald | $91 → $100 | Maintains | Neutral |
06/06/2023 | 26.66% | Benchmark | → $115 | Reiterates | Buy → Buy |
06/06/2023 | 10.14% | Credit Suisse | $115 → $100 | Downgrades | Outperform → Neutral |
05/08/2023 | -7.48% | TD Cowen | $95 → $84 | Maintains | Market Perform |
05/05/2023 | -3.07% | Barclays | $93 → $88 | Maintains | Equal-Weight |
05/04/2023 | 6.84% | Truist Securities | $115 → $97 | Maintains | Buy |
05/04/2023 | 13.45% | Stephens & Co. | → $103 | Reiterates | → Equal-Weight |
04/21/2023 | -4.18% | Cantor Fitzgerald | → $87 | Initiates Coverage On | → Neutral |
04/13/2023 | 26.66% | Truist Securities | $130 → $115 | Maintains | Buy |
03/14/2023 | 26.66% | Benchmark | → $115 | Reiterates | → Buy |
03/14/2023 | 13.45% | Stephens & Co. | → $103 | Reiterates | → Equal-Weight |
03/13/2023 | 2.43% | Barclays | → $93 | Initiates Coverage On | → Equal-Weight |
02/27/2023 | 26.66% | Credit Suisse | → $115 | Reiterates | → Outperform |
02/21/2023 | 22.26% | RBC Capital | $114 → $111 | Maintains | Outperform |
02/16/2023 | 4.64% | Stephens & Co. | → $95 | Reiterates | → Equal-Weight |
02/16/2023 | 26.66% | Benchmark | $120 → $115 | Maintains | Buy |
02/13/2023 | 32.17% | Benchmark | → $120 | Reiterates | → Buy |
01/25/2023 | 32.17% | Benchmark | $135 → $120 | Maintains | Buy |
01/23/2023 | 26.66% | Credit Suisse | $140 → $115 | Maintains | Outperform |
01/19/2023 | 37.68% | Oppenheimer | $145 → $125 | Maintains | Outperform |
01/05/2023 | -6.38% | SVB Leerink | $96 → $85 | Maintains | Market Perform |
11/11/2022 | 16.75% | Stephens & Co. | $122 → $106 | Maintains | Equal-Weight |
11/01/2022 | 5.74% | SVB Leerink | $116 → $96 | Maintains | Market Perform |
11/01/2022 | 34.37% | Stephens & Co. | $105 → $122 | Maintains | Equal-Weight |
10/31/2022 | 53.1% | RBC Capital | $165 → $139 | Maintains | Outperform |
10/28/2022 | 38.78% | Barclays | $154 → $126 | Maintains | Overweight |
10/28/2022 | 15.65% | Stephens & Co. | $120 → $105 | Maintains | Equal-Weight |
10/28/2022 | 43.19% | Truist Securities | $140 → $130 | Maintains | Buy |
10/28/2022 | 59.71% | Oppenheimer | $175 → $145 | Maintains | Outperform |
10/27/2022 | — | Raymond James | Downgrades | Outperform → Market Perform | |
10/24/2022 | 81.74% | Deutsche Bank | $175 → $165 | Maintains | Buy |
10/05/2022 | 54.2% | Truist Securities | $150 → $140 | Maintains | Buy |
10/03/2022 | 48.69% | Benchmark | $165 → $135 | Maintains | Buy |
08/02/2022 | 4.64% | UBS | $145 → $95 | Downgrades | Neutral → Sell |
08/01/2022 | 54.2% | Raymond James | $180 → $140 | Maintains | Outperform |
07/29/2022 | 69.62% | Barclays | $181 → $154 | Maintains | Overweight |
07/28/2022 | 81.74% | Benchmark | $175 → $165 | Maintains | Buy |
07/14/2022 | 65.21% | Truist Securities | $175 → $150 | Maintains | Buy |
06/29/2022 | 40.98% | Stifel | → $128 | Initiates Coverage On | → Hold |
06/21/2022 | 12.35% | B of A Securities | $145 → $102 | Downgrades | Neutral → Underperform |
06/21/2022 | 92.75% | Deutsche Bank | $210 → $175 | Maintains | Buy |
06/21/2022 | 92.75% | Truist Securities | $200 → $175 | Maintains | Buy |
06/21/2022 | 37.68% | Stephens & Co. | $155 → $125 | Maintains | Equal-Weight |
06/21/2022 | 17.85% | SVB Leerink | $117 → $107 | Maintains | Market Perform |
05/27/2022 | 28.87% | SVB Leerink | $131 → $117 | Maintains | Market Perform |
04/29/2022 | 100.46% | Credit Suisse | $181 → $182 | Maintains | Outperform |
04/29/2022 | 98.26% | Raymond James | $200 → $180 | Maintains | Outperform |
04/29/2022 | 44.29% | SVB Leerink | $162 → $131 | Maintains | Market Perform |
03/01/2022 | 85.04% | UBS | $152 → $168 | Upgrades | Sell → Neutral |
02/25/2022 | 114.78% | Credit Suisse | $200 → $195 | Maintains | Outperform |
02/25/2022 | 120.29% | Oppenheimer | $225 → $200 | Maintains | Outperform |
02/25/2022 | 109.27% | BMO Capital | → $190 | Upgrades | Market Perform → Outperform |
02/24/2022 | 92.75% | Benchmark | $200 → $175 | Maintains | Buy |
02/18/2022 | 61.91% | SVB Leerink | $145 → $147 | Maintains | Market Perform |
12/21/2021 | 134.6% | Barclays | $236 → $213 | Maintains | Overweight |
11/08/2021 | 147.82% | Raymond James | $250 → $225 | Maintains | Outperform |
11/04/2021 | 125.79% | Credit Suisse | $192 → $205 | Maintains | Outperform |
11/04/2021 | 103.76% | Stephens & Co. | $178 → $185 | Maintains | Equal-Weight |
11/04/2021 | 143.42% | RBC Capital | $244 → $221 | Maintains | Outperform |
11/04/2021 | 99.36% | SVB Leerink | $170 → $181 | Maintains | Market Perform |
11/03/2021 | 147.82% | Oppenheimer | $265 → $225 | Maintains | Outperform |
10/13/2021 | 109.27% | Truist Securities | $255 → $190 | Maintains | Buy |
09/27/2021 | 87.24% | SVB Leerink | → $170 | Initiates Coverage On | → Market Perform |
09/24/2021 | 65.21% | UBS | → $150 | Initiates Coverage On | → Sell |
09/10/2021 | 114.78% | Cowen & Co. | → $195 | Initiates Coverage On | → Market Perform |
08/11/2021 | 175.36% | Credit Suisse | $330 → $250 | Maintains | Outperform |
08/10/2021 | 158.84% | Benchmark | $325 → $235 | Maintains | Buy |
08/10/2021 | 175.36% | Raymond James | $325 → $250 | Maintains | Outperform |
08/06/2021 | 191.88% | Oppenheimer | $325 → $265 | Maintains | Outperform |
08/06/2021 | 161.04% | Stephens & Co. | $310 → $237 | Maintains | Equal-Weight |
08/05/2021 | 142.31% | B of A Securities | → $220 | Downgrades | Buy → Neutral |
02/23/2021 | 257.96% | Benchmark | $275 → $325 | Maintains | Buy |
02/08/2021 | 274.49% | Deutsche Bank | $275 → $340 | Maintains | Buy |
10/30/2020 | 208.4% | Credit Suisse | $246 → $280 | Maintains | Outperform |
09/21/2020 | 186.37% | Oppenheimer | $250 → $260 | Maintains | Outperform |
09/02/2020 | 197.39% | BMO Capital | $250 → $270 | Maintains | Market Perform |
07/30/2020 | 197.39% | SunTrust Robinson Humphrey | $260 → $270 | Maintains | Buy |
07/30/2020 | 180.86% | Raymond James | $210 → $255 | Maintains | Outperform |
07/30/2020 | 186.37% | Deutsche Bank | $220 → $260 | Maintains | Buy |
07/30/2020 | 175.36% | Benchmark | $210 → $250 | Maintains | Buy |
07/30/2020 | 186.37% | RBC Capital | $218 → $260 | Maintains | Outperform |
07/29/2020 | 175.36% | Jefferies | $225 → $250 | Maintains | Buy |
07/10/2020 | 186.37% | SunTrust Robinson Humphrey | $240 → $260 | Maintains | Buy |
06/18/2020 | 131.3% | Benchmark | → $210 | Upgrades | Hold → Buy |
05/21/2020 | 164.34% | SunTrust Robinson Humphrey | $225 → $240 | Maintains | Buy |
05/11/2020 | 109.27% | UBS | $208 → $190 | Maintains | Neutral |
05/11/2020 | 131.3% | Raymond James | $225 → $210 | Maintains | Outperform |
03/09/2020 | 125.79% | Benchmark | → $205 | Upgrades | Hold → Buy |
02/21/2020 | 129.1% | UBS | $154 → $208 | Maintains | Neutral |
02/21/2020 | 120.29% | Stephens & Co. | $180 → $200 | Maintains | Equal-Weight |
02/20/2020 | 147.82% | SunTrust Robinson Humphrey | $185 → $225 | Maintains | Buy |
02/20/2020 | 147.82% | Raymond James | $200 → $225 | Maintains | Outperform |
01/17/2020 | 126.89% | Credit Suisse | → $206 | Initiates Coverage On | → Outperform |
01/03/2020 | 120.29% | Raymond James | $144 → $200 | Maintains | Outperform |
12/18/2019 | 103.76% | SunTrust Robinson Humphrey | $175 → $185 | Maintains | Buy |
12/06/2019 | 87.24% | BMO Capital | → $170 | Initiates Coverage On | → Market Perform |
11/26/2019 | 96.05% | B of A Securities | $170 → $178 | Maintains | Buy |
11/20/2019 | 87.24% | B of A Securities | $163 → $170 | Reiterates | → Buy |
11/07/2019 | 69.62% | UBS | $144 → $154 | Maintains | Neutral |
11/01/2019 | — | Baird | Upgrades | Neutral → Outperform | |
10/22/2019 | 59.71% | Stephens & Co. | → $145 | Reinstates | → Equal-Weight |
09/17/2019 | 70.72% | Deutsche Bank | → $155 | Initiates Coverage On | → Buy |
08/05/2019 | 37.68% | Barclays | $120 → $125 | Maintains | Equal-Weight |
07/15/2019 | 58.61% | Raymond James | $140 → $144 | Maintains | Outperform |
05/02/2019 | 54.2% | Raymond James | → $140 | Upgrades | Market Perform → Outperform |
03/21/2019 | 32.17% | Barclays | $115 → $120 | Maintains | Equal-Weight |
02/05/2019 | — | Benchmark | Downgrades | Buy → Hold | |
12/14/2018 | 43.19% | Barclays | → $130 | Initiates Coverage On | → Equal-Weight |
11/16/2018 | 38.78% | UBS | → $126 | Initiates Coverage On | → Neutral |
10/30/2018 | — | Benchmark | Upgrades | Hold → Buy | |
10/26/2018 | 14.55% | Craig-Hallum | $116 → $104 | Downgrades | Buy → Hold |
10/11/2018 | 32.17% | Baird | $105 → $120 | Maintains | Neutral |
10/11/2018 | 37.68% | Cantor Fitzgerald | $117 → $125 | Maintains | Neutral |
09/18/2018 | 53.1% | B of A Securities | $116 → $139 | Maintains | Buy |
09/13/2018 | 28.87% | Cantor Fitzgerald | → $117 | Initiates Coverage On | → Neutral |
日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
---|---|---|---|---|---|
07/31/2023 | 11.24% | TD Cowen | $84→$101 | 维护 | 市场表现 |
07/27/2023 | 11.24% | 瑞士信贷 | →$101 | 重申 | 中性→中性 |
07/06/2023 | 11.24% | 杰富瑞 | $98→$101 | 评级下调 | 购买→Hold |
2023年6月28日 | - | 基准 | 评级下调 | 购买→Hold | |
2023年6月27日 | - | 基准 | 评级下调 | 购买→Hold | |
2023年6月27日 | 11.24% | Truist证券 | $97→$101 | 维护 | 保持 |
06/07/2023 | 6.84% | Truist证券 | →$97 | 评级下调 | 购买→Hold |
06/06/2023 | 10.14% | 康托·菲茨杰拉德 | $91→$100 | 维护 | 中性 |
06/06/2023 | 26.66% | 基准 | →$115 | 重申 | 购买→购买 |
06/06/2023 | 10.14% | 瑞士信贷 | $115→$100 | 评级下调 | 跑赢→中性 |
05/08/2023 | -7.48% | TD Cowen | $95→$84 | 维护 | 市场表现 |
05/05/2023 | -3.07% | 巴克莱 | $93→$88 | 维护 | 等重 |
05/04/2023 | 6.84% | Truist证券 | $115→$97 | 维护 | 买 |
05/04/2023 | 13.45% | 斯蒂芬斯公司 | →$103 | 重申 | →等重 |
04/21/2023 | -4.18% | 康托·菲茨杰拉德 | →$87 | 开始承保 | →中性 |
04/13/2023 | 26.66% | Truist证券 | $130→$115 | 维护 | 买 |
03/14/2023 | 26.66% | 基准 | →$115 | 重申 | →购买 |
03/14/2023 | 13.45% | 斯蒂芬斯公司 | →$103 | 重申 | →等重 |
03/13/2023 | 2.43% | 巴克莱 | →$93 | 开始承保 | →等重 |
02/27/2023 | 26.66% | 瑞士信贷 | →$115 | 重申 | →跑赢大盘 |
02/21/2023 | 22.26% | 加拿大皇家银行资本 | $114→$111 | 维护 | 跑赢大盘 |
02/16/2023 | 4.64% | 斯蒂芬斯公司 | →$95 | 重申 | →等重 |
02/16/2023 | 26.66% | 基准 | $120→$115 | 维护 | 买 |
02/13/2023 | 32.17% | 基准 | →$120 | 重申 | →购买 |
2023年1月25日 | 32.17% | 基准 | $135→$120 | 维护 | 买 |
2023年1月23日 | 26.66% | 瑞士信贷 | $140→$115 | 维护 | 跑赢大盘 |
2023年1月19日 | 37.68% | 奥本海默 | $145→$125 | 维护 | 跑赢大盘 |
01/05/2023 | -6.38% | SVB Leerink | $96→$85 | 维护 | 市场表现 |
2022年11月11日 | 16.75% | 斯蒂芬斯公司 | $122→$106 | 维护 | 等重 |
11/01/2022 | 5.74% | SVB Leerink | $116→$96 | 维护 | 市场表现 |
11/01/2022 | 34.37% | 斯蒂芬斯公司 | $105→$122 | 维护 | 等重 |
2022年10月31日 | 53.1% | 加拿大皇家银行资本 | $165→$139 | 维护 | 跑赢大盘 |
10/28/2022 | 38.78% | 巴克莱 | $154→$126 | 维护 | 超重 |
10/28/2022 | 15.65% | 斯蒂芬斯公司 | $120→$105 | 维护 | 等重 |
10/28/2022 | 43.19% | Truist证券 | $140→$130 | 维护 | 买 |
10/28/2022 | 59.71% | 奥本海默 | $175→$145 | 维护 | 跑赢大盘 |
10/27/2022 | - | 雷蒙德·詹姆斯 | 评级下调 | 跑赢→市场表现 | |
10/24/2022 | 81.74% | 德意志银行 | $175→$165 | 维护 | 买 |
10/05/2022 | 54.2% | Truist证券 | $150→$140 | 维护 | 买 |
10/03/2022 | 48.69% | 基准 | $165→$135 | 维护 | 买 |
08/02/2022 | 4.64% | 瑞银集团 | $145→$95 | 评级下调 | 中性→销售 |
08/01/2022 | 54.2% | 雷蒙德·詹姆斯 | $180→$140 | 维护 | 跑赢大盘 |
07/29/2022 | 69.62% | 巴克莱 | $181→$154 | 维护 | 超重 |
07/28/2022 | 81.74% | 基准 | $175→$165 | 维护 | 买 |
07/14/2022 | 65.21% | Truist证券 | $175→$150 | 维护 | 买 |
2022/06/29 | 40.98% | Stifel | →$128 | 开始承保 | →保留 |
2022年06月21日 | 12.35% | B of A证券 | $145→$102 | 评级下调 | 中性→表现不佳 |
2022年06月21日 | 92.75% | 德意志银行 | $210→$175 | 维护 | 买 |
2022年06月21日 | 92.75% | Truist证券 | $200→$175 | 维护 | 买 |
2022年06月21日 | 37.68% | 斯蒂芬斯公司 | $155→$125 | 维护 | 等重 |
2022年06月21日 | 17.85% | SVB Leerink | $117→$107 | 维护 | 市场表现 |
2022年05月27日 | 28.87% | SVB Leerink | $131→$117 | 维护 | 市场表现 |
04/29/2022 | 100.46% | 瑞士信贷 | $181→$182 | 维护 | 跑赢大盘 |
04/29/2022 | 98.26% | 雷蒙德·詹姆斯 | $200→$180 | 维护 | 跑赢大盘 |
04/29/2022 | 44.29% | SVB Leerink | $162→$131 | 维护 | 市场表现 |
03/01/2022 | 85.04% | 瑞银集团 | $152→$168 | 升级 | 卖出→中性 |
02/25/2022 | 114.78% | 瑞士信贷 | $200→$195 | 维护 | 跑赢大盘 |
02/25/2022 | 120.29% | 奥本海默 | $225→$200 | 维护 | 跑赢大盘 |
02/25/2022 | 109.27% | 蒙特利尔银行资本 | →$190 | 升级 | 市场表现优于→ |
02/24/2022 | 92.75% | 基准 | $200→$175 | 维护 | 买 |
02/18/2022 | 61.91% | SVB Leerink | $145→$147 | 维护 | 市场表现 |
2021/12/21 | 134.6% | 巴克莱 | $236→$213 | 维护 | 超重 |
11/08/2021 | 147.82% | 雷蒙德·詹姆斯 | $250→$225 | 维护 | 跑赢大盘 |
11/04/2021 | 125.79% | 瑞士信贷 | $192→$205 | 维护 | 跑赢大盘 |
11/04/2021 | 103.76% | 斯蒂芬斯公司 | $178→$185 | 维护 | 等重 |
11/04/2021 | 143.42% | 加拿大皇家银行资本 | $244→$221 | 维护 | 跑赢大盘 |
11/04/2021 | 99.36% | SVB Leerink | $170→$181 | 维护 | 市场表现 |
11/03/2021 | 147.82% | 奥本海默 | $265→$225 | 维护 | 跑赢大盘 |
10/13/2021 | 109.27% | Truist证券 | $255→$190 | 维护 | 买 |
09/27/2021 | 87.24% | SVB Leerink | →$170 | 开始承保 | →市场表现 |
09/24/2021 | 65.21% | 瑞银集团 | →$150 | 开始承保 | →销售 |
09/10/2021 | 114.78% | 考恩公司 | →$195 | 开始承保 | →市场表现 |
2021/08/11 | 175.36% | 瑞士信贷 | $330→$250 | 维护 | 跑赢大盘 |
2021/08/10 | 158.84% | 基准 | $325→$235 | 维护 | 买 |
2021/08/10 | 175.36% | 雷蒙德·詹姆斯 | $325→$250 | 维护 | 跑赢大盘 |
08/06/2021 | 191.88% | 奥本海默 | $325→$265 | 维护 | 跑赢大盘 |
08/06/2021 | 161.04% | 斯蒂芬斯公司 | $310→$237 | 维护 | 等重 |
08/05/2021 | 142.31% | B of A证券 | →$220 | 评级下调 | 购买→中性 |
02/23/2021 | 257.96% | 基准 | $275→$325 | 维护 | 买 |
02/08/2021 | 274.49% | 德意志银行 | $275→$340 | 维护 | 买 |
10/30/2020 | 208.4% | 瑞士信贷 | $246→$280 | 维护 | 跑赢大盘 |
2020/09/21 | 186.37% | 奥本海默 | $250→$260 | 维护 | 跑赢大盘 |
09/02/2020 | 197.39% | 蒙特利尔银行资本 | $250→$270 | 维护 | 市场表现 |
07/30/2020 | 197.39% | SunTrust Robinson Humphrey | $260→$270 | 维护 | 买 |
07/30/2020 | 180.86% | 雷蒙德·詹姆斯 | $210→$255 | 维护 | 跑赢大盘 |
07/30/2020 | 186.37% | 德意志银行 | $220→$260 | 维护 | 买 |
07/30/2020 | 175.36% | 基准 | $210→$250 | 维护 | 买 |
07/30/2020 | 186.37% | 加拿大皇家银行资本 | $218→$260 | 维护 | 跑赢大盘 |
07/29/2020 | 175.36% | 杰富瑞 | $225→$250 | 维护 | 买 |
07/10/2020 | 186.37% | SunTrust Robinson Humphrey | $240→$260 | 维护 | 买 |
06/18/2020 | 131.3% | 基准 | →$210 | 升级 | 持有→购买 |
2020/05/21 | 164.34% | SunTrust Robinson Humphrey | $225→$240 | 维护 | 买 |
05/11/2020 | 109.27% | 瑞银集团 | $208→$190 | 维护 | 中性 |
05/11/2020 | 131.3% | 雷蒙德·詹姆斯 | $225→$210 | 维护 | 跑赢大盘 |
03/09/2020 | 125.79% | 基准 | →$205 | 升级 | 持有→购买 |
02/21/2020 | 129.1% | 瑞银集团 | $154→$208 | 维护 | 中性 |
02/21/2020 | 120.29% | 斯蒂芬斯公司 | $180→$200 | 维护 | 等重 |
02/20/2020 | 147.82% | SunTrust Robinson Humphrey | $185→$225 | 维护 | 买 |
02/20/2020 | 147.82% | 雷蒙德·詹姆斯 | $200→$225 | 维护 | 跑赢大盘 |
2020/01/17 | 126.89% | 瑞士信贷 | →$206 | 开始承保 | →跑赢大盘 |
1/03/2020 | 120.29% | 雷蒙德·詹姆斯 | $144→$200 | 维护 | 跑赢大盘 |
2019年12月18日 | 103.76% | SunTrust Robinson Humphrey | $175→$185 | 维护 | 买 |
2019年6月12日 | 87.24% | 蒙特利尔银行资本 | →$170 | 开始承保 | →市场表现 |
2019年11月26日 | 96.05% | B of A证券 | $170→$178 | 维护 | 买 |
2019年11月20日 | 87.24% | B of A证券 | $163→$170 | 重申 | →购买 |
2019/07/11 | 69.62% | 瑞银集团 | $144→$154 | 维护 | 中性 |
2019/11/01 | - | 贝尔德 | 升级 | 中性→表现优异 | |
2019年10月22日 | 59.71% | 斯蒂芬斯公司 | →$145 | 恢复 | →等重 |
2019/09/17 | 70.72% | 德意志银行 | →$155 | 开始承保 | →购买 |
2019年08月05日 | 37.68% | 巴克莱 | $120→$125 | 维护 | 等重 |
2019年07月15日 | 58.61% | 雷蒙德·詹姆斯 | $140→$144 | 维护 | 跑赢大盘 |
2019年05月02日 | 54.2% | 雷蒙德·詹姆斯 | →$140 | 升级 | 市场表现优于→ |
2019年03月21日 | 32.17% | 巴克莱 | $115→$120 | 维护 | 等重 |
2019年05月02日 | - | 基准 | 评级下调 | 购买→Hold | |
2018年12月14日 | 43.19% | 巴克莱 | →$130 | 开始承保 | →等重 |
2018年11月16日 | 38.78% | 瑞银集团 | →$126 | 开始承保 | →中性 |
2018年10月30日 | - | 基准 | 升级 | 持有→购买 | |
2018年10月26日 | 14.55% | 克雷格-哈勒姆 | $116→$104 | 评级下调 | 购买→Hold |
2018年10月11日 | 32.17% | 贝尔德 | $105→$120 | 维护 | 中性 |
2018年10月11日 | 37.68% | 康托·菲茨杰拉德 | $117→$125 | 维护 | 中性 |
2018年09月18日 | 53.1% | B of A证券 | $116→$139 | 维护 | 买 |
2018年09月13日 | 28.87% | 康托·菲茨杰拉德 | →$117 | 开始承保 | →中性 |
What is the target price for Amedisys (AMED)?
Amedisys(Amed)的目标价是多少?
The latest price target for Amedisys (NASDAQ: AMED) was reported by TD Cowen on July 31, 2023. The analyst firm set a price target for $101.00 expecting AMED to rise to within 12 months (a possible 11.24% upside). 42 analyst firms have reported ratings in the last year.
TD Cowen于2023年7月31日报道了Amedisys(纳斯达克代码:AMED)的最新目标价。这家分析公司将目标价定为101.00美元,预计Amed将在12个月内上涨至11.24%(可能上涨11.24%)。去年有42家分析公司公布了评级。
What is the most recent analyst rating for Amedisys (AMED)?
Amedisys(Amed)的最新分析师评级是多少?
The latest analyst rating for Amedisys (NASDAQ: AMED) was provided by TD Cowen, and Amedisys maintained their market perform rating.
TD Cowen提供了对Amedisys(纳斯达克代码:AMED)的最新分析师评级,Amedisys维持其市场表现评级。
When is the next analyst rating going to be posted or updated for Amedisys (AMED)?
Amedisys(Amed)的下一次分析师评级将于何时发布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amedisys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amedisys was filed on July 31, 2023 so you should expect the next rating to be made available sometime around July 31, 2024.
分析师在进行了广泛的研究后得出了股票评级,其中包括查阅公共财务报表,与Amedisys的高管和客户交谈,以及听取收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。Amedisys的上一次评级是在2023年7月31日提交的,所以你应该预计下一次评级将在2024年7月31日左右的某个时候公布。
Is the Analyst Rating Amedisys (AMED) correct?
分析师对Amedisys(Amed)的评级正确吗?
While ratings are subjective and will change, the latest Amedisys (AMED) rating was a maintained with a price target of $84.00 to $101.00. The current price Amedisys (AMED) is trading at is $90.79, which is within the analyst's predicted range.
虽然评级是主观的,并将发生变化,但最新的Amedisys(AMED)评级维持不变,目标价在84美元至101.00美元之间。Amedisys(Amed)目前的交易价格为90.79美元,在分析师的预测区间内。